The number of people with susceptibility test result for rifampicin in Korea
Korea: The number of people with susceptibility test result for rifampicin was 82.06 in 2021. ▬ Flat
Latest (2021)
82.06
Change on year
down 7.7%
World rank
91st
of 146 countries
All-time high
88.87
in 2020
All-time low
81.26
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Korea, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Korea is 82.06, measured in 2021.
Compared with earlier readings it is down 7.7% on the previous year and up 1.0% over five years.
Korea ranks 91st of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Korea, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 81.26 | — |
| 2018 | 84.53 | +4.0% |
| 2019 | 87.75 | +3.8% |
| 2020 | 88.87 | +1.3% |
| 2021 | 82.06 | -7.7% |
Korea compared with similar countries
- Korea's 82.06 is below the median for high income countries, which is 92.6, 89% of the median. (56 countries reporting)
- Korea's 82.06 is below the median for East Asia & Pacific, which is 96.47, 85% of the median. (28 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 84.51 | 81.26 | 87.75 | 3 |
| 2020s | 85.46 | 82.06 | 88.87 | 2 |
Countries ranked near Korea
More health data for Korea
- Un projection of annual infant deaths, annual growth rate -1.43 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1935 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 2,072 deaths per 1,000 people (2090)
- Number of infants who die before age 1 69 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.66 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0118 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.76 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Korea?
- The number of people with susceptibility test result for rifampicin in Korea was 82.06 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Korea?
- The highest recorded value was 88.87 in 2020.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Korea?
- The lowest recorded value was 81.26 in 2017.
- How does Korea rank for the number of people with susceptibility test result for rifampicin?
- Korea ranks 91st out of 146 countries with data for 2021.
- Where does this Korea data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).